Cordlife Group Limited Stock Net Income
| CLIFF Stock | USD 0.07 0.00 0.00% |
As of the 12th of February 2026, Cordlife Group shows the Standard Deviation of 4.08, mean deviation of 0.9332, and Risk Adjusted Performance of (0.05). Cordlife Group technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cordlife Group coefficient of variation, as well as the relationship between the total risk alpha and skewness to decide if Cordlife Group is priced correctly, providing market reflects its regular price of 0.0689 per share. As Cordlife Group appears to be a penny stock we also recommend to validate its information ratio numbers.
Cordlife Group's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Cordlife Group's valuation are provided below:Cordlife Group Limited does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Cordlife |
Cordlife Group 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cordlife Group's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cordlife Group.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Cordlife Group on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Cordlife Group Limited or generate 0.0% return on investment in Cordlife Group over 90 days. Cordlife Group is related to or competes with Starpharma Holdings, BioMark Diagnostics, Izotropic, Bonus BioGroup, Positron Corp, Finch Therapeutics, and Marpai. Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, Ind... More
Cordlife Group Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cordlife Group's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cordlife Group Limited upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 42.09 |
Cordlife Group Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cordlife Group's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cordlife Group's standard deviation. In reality, there are many statistical measures that can use Cordlife Group historical prices to predict the future Cordlife Group's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (0.80) | |||
| Treynor Ratio | (0.42) |
Cordlife Group February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.41) | |||
| Mean Deviation | 0.9332 | |||
| Coefficient Of Variation | (1,339) | |||
| Standard Deviation | 4.08 | |||
| Variance | 16.64 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (0.80) | |||
| Treynor Ratio | (0.42) | |||
| Maximum Drawdown | 42.09 | |||
| Skewness | (6.49) | |||
| Kurtosis | 52.63 |
Cordlife Group Backtested Returns
Cordlife Group secures Sharpe Ratio (or Efficiency) of -0.13, which signifies that the company had a -0.13 % return per unit of risk over the last 3 months. Cordlife Group Limited exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cordlife Group's Standard Deviation of 4.08, mean deviation of 0.9332, and Risk Adjusted Performance of (0.05) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.76, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cordlife Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cordlife Group is expected to be smaller as well. At this point, Cordlife Group has a negative expected return of -0.49%. Please make sure to confirm Cordlife Group's information ratio, skewness, as well as the relationship between the Skewness and day median price , to decide if Cordlife Group performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
Cordlife Group Limited has no correlation between past and present. Overlapping area represents the amount of predictability between Cordlife Group time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cordlife Group price movement. The serial correlation of 0.0 indicates that just 0.0% of current Cordlife Group price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.82 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Cordlife Group Limited reported net income of 6.13 M. This is 98.2% lower than that of the Healthcare sector and 96.46% lower than that of the Diagnostics & Research industry. The net income for all United States stocks is 98.93% higher than that of the company.
Cordlife Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cordlife Group's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Cordlife Group could also be used in its relative valuation, which is a method of valuing Cordlife Group by comparing valuation metrics of similar companies.Cordlife Group is currently under evaluation in net income category among its peers.
Cordlife Fundamentals
| Return On Equity | 0.0414 | |||
| Return On Asset | 0.0105 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 8.23 M | |||
| Shares Outstanding | 255.98 M | |||
| Shares Owned By Insiders | 65.41 % | |||
| Shares Owned By Institutions | 6.78 % | |||
| Price To Earning | 13.00 X | |||
| Price To Book | 0.57 X | |||
| Price To Sales | 1.04 X | |||
| Revenue | 56.67 M | |||
| Gross Profit | 39.48 M | |||
| EBITDA | 10.78 M | |||
| Net Income | 6.13 M | |||
| Cash And Equivalents | 64.95 M | |||
| Cash Per Share | 0.25 X | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 4.12 X | |||
| Book Value Per Share | 0.53 X | |||
| Cash Flow From Operations | 9.5 M | |||
| Earnings Per Share | 0.02 X | |||
| Number Of Employees | 33 | |||
| Beta | 0.65 | |||
| Market Capitalization | 63.7 M | |||
| Total Asset | 233.71 M | |||
| Retained Earnings | 54 M | |||
| Working Capital | 130 M | |||
| Current Asset | 163 M | |||
| Current Liabilities | 33 M | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 233.71 M | |||
| Last Dividend Paid | 0.009 |
About Cordlife Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cordlife Group Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cordlife Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cordlife Group Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Cordlife Pink Sheet
Cordlife Group financial ratios help investors to determine whether Cordlife Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cordlife with respect to the benefits of owning Cordlife Group security.